Cargando…
Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets
The mechanisms underlying type 1 diabetes (T1D) pathogenesis remain largely unknown. While autoantibodies to pancreatic beta-cell antigens are often the first biological response and thereby a useful biomarker for identifying individuals in early stages of T1D, their role in T1D pathogenesis is not...
Autores principales: | Rodriguez-Calvo, Teresa, Johnson, James D., Overbergh, Lut, Dunne, Jessica L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089389/ https://www.ncbi.nlm.nih.gov/pubmed/33953728 http://dx.doi.org/10.3389/fimmu.2021.667989 |
Ejemplares similares
-
Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery
por: de Sousa, Eric, et al.
Publicado: (2021) -
Citrullination and PAD Enzyme Biology in Type 1 Diabetes – Regulators of Inflammation, Autoimmunity, and Pathology
por: Yang, Mei-Ling, et al.
Publicado: (2021) -
Posttranslational Modifications of Proteins in Type 1 Diabetes: The Next Step in Finding the Cure?
por: Dunne, Jessica L., et al.
Publicado: (2012) -
Corpora Amylacea in the Human Brain Exhibit Neoepitopes of a Carbohydrate Nature
por: Riba, Marta, et al.
Publicado: (2021) -
An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
por: Bjerregaard, Anne-Mette, et al.
Publicado: (2017)